Skip to content

DiaCarta, Inc. vs Geneseeq Technology Inc.

DiaCarta, Inc. logo

DiaCarta, Inc.

Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection

40 employees · est. 2012 · Pleasanton, United States

VS
Geneseeq Technology Inc. logo

Geneseeq Technology Inc.

Cancer: a word, not a sentence!

32 employees · est. 2012 · Toronto, Canada

Side-by-Side Comparison

DiaCarta, Inc. Geneseeq Technology Inc.
Founded
2012 2012
Headquarters
Pleasanton, United States Toronto, Canada
Employees
40 32
Industry
Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series D
Total Funding
$53.00M $940.00M
Funding Rounds
2 5
Services
Not tracked yet Central Lab Testing, Local Testing Solutions, IVD Kit Solutions, RUO Kit Solutions, Research Services, DNA Sequencing, RNA Sequencing, Project Management, Data Analysis, Sample Logistics and Storage, Customized QC/QA Solutions
Target Customers
Not tracked yet Oncologists, Physicians, Researchers, Pharma/Biopharma Companies, Biotechnology Firms, Hospitals, Research Institutions, Distributors, Lab Services
Taxonomy
Precision Molecular DiagnosticsTranslational GenomicsCLIA LabLiquid BiopsyCancer Mutation DetectionColorectal Cancer Mutation Detection +9 Precision OncologyNext-Generation SequencingCancer DetectionIn Vitro DiagnosticsResearch Use Only TestingPan-Cancer Panels +9
Website
diacarta.com na.geneseeq.com
DiaCarta, Inc. logo

About DiaCarta, Inc.

DiaCarta, Inc. is a biotechnology startup that has been shaping the future of precision molecular diagnostics since its inception in 2011. The company's slogan, "Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection," reflects its mission to revolutionize cancer diagnosis...

Geneseeq Technology Inc. logo

About Geneseeq Technology Inc.

Geneseeq Technology Inc. is a pioneering force in the field of precision oncology, leveraging next-generation sequencing (NGS) technologies to revolutionize cancer detection, diagnosis, and treatment. Operating from dual headquarters in Canada and China, the company upholds rigorous quality standard...

Also comparing in this category

Comparing more than these two?

Get DiaCarta, Inc., Geneseeq Technology Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does DiaCarta, Inc. compare?

A PDF of DiaCarta, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

DiaCarta, Inc. was founded in 2012, based in Pleasanton, United States, with 40 employees. DiaCarta, Inc. is a biotechnology startup that has been shaping the future of precision molecular diagnostics since its inception in 2011. The company's slogan, "Redefining Precision Molecular Diagnos. Geneseeq Technology Inc. was founded in 2012, based in Toronto, Canada, with 32 employees. Geneseeq Technology Inc. is a pioneering force in the field of precision oncology, leveraging next-generation sequencing (NGS) technologies to revolutionize cancer detection, diagnosis, and treatment.
DiaCarta, Inc. has raised $53.00M and Geneseeq Technology Inc. $940.00M. Latest stage: DiaCarta, Inc. Series B, Geneseeq Technology Inc. Series D.
Both work in Biotechnology.

Compare DiaCarta, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DiaCarta, Inc. on 12 Sep 2024, and Geneseeq Technology Inc. on 11 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout